Single-Cell RNA Profiling Reveals Adipocyte to Macrophage Signaling Sufficient to Enhance Thermogenesis.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
04 08 2020
Historique:
received: 05 05 2020
revised: 22 06 2020
accepted: 15 07 2020
entrez: 7 8 2020
pubmed: 7 8 2020
medline: 4 5 2021
Statut: ppublish

Résumé

Adipocytes deficient in fatty acid synthase (iAdFASNKO) emit signals that mimic cold exposure to enhance the appearance of thermogenic beige adipocytes in mouse inguinal white adipose tissues (iWATs). Both cold exposure and iAdFASNKO upregulate the sympathetic nerve fiber (SNF) modulator Neuregulin 4 (Nrg4), activate SNFs, and require adipocyte cyclic AMP/protein kinase A (cAMP/PKA) signaling for beige adipocyte appearance, as it is blocked by adipocyte Gsα deficiency. Surprisingly, however, in contrast to cold-exposed mice, neither iWAT denervation nor Nrg4 loss attenuated adipocyte browning in iAdFASNKO mice. Single-cell transcriptomic analysis of iWAT stromal cells revealed increased macrophages displaying gene expression signatures of the alternately activated type in iAdFASNKO mice, and their depletion abrogated iWAT beiging. Altogether, these findings reveal that divergent cellular pathways are sufficient to cause adipocyte browning. Importantly, adipocyte signaling to enhance alternatively activated macrophages in iAdFASNKO mice is associated with enhanced adipose thermogenesis independent of the sympathetic neuron involvement this process requires in the cold.

Identifiants

pubmed: 32755590
pii: S2211-1247(20)30983-9
doi: 10.1016/j.celrep.2020.107998
pmc: PMC7433376
mid: NIHMS1617897
pii:
doi:

Substances chimiques

Neuregulins 0
Uncoupling Protein 1 0
neuregulin-4 0
RNA 63231-63-0
Cyclic AMP E0399OZS9N
Fatty Acid Synthases EC 2.3.1.85

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107998

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK116056
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK120649
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK089503
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI147868
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK102456
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020541
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK030898
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK030898
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK103047
Pays : United States

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Cell. 2012 Jul 20;150(2):366-76
pubmed: 22796012
Front Endocrinol (Lausanne). 2012 Jan 03;2:102
pubmed: 22654837
Nat Commun. 2015 Aug 05;6:7906
pubmed: 26243466
Mol Metab. 2017 May 31;6(8):781-796
pubmed: 28752043
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Obesity (Silver Spring). 2019 Oct;27(10):1555-1557
pubmed: 31479202
Diabetes. 2009 Jul;58(7):1526-31
pubmed: 19401428
Cell Metab. 2014 Jan 7;19(1):162-171
pubmed: 24374218
Metabolism. 2018 Apr;81:63-70
pubmed: 29155135
Nat Med. 2015 Dec;21(12):1497-1501
pubmed: 26569380
Am J Physiol Endocrinol Metab. 2014 Apr 15;306(8):E945-64
pubmed: 24549398
Protein Cell. 2018 Jun;9(6):527-539
pubmed: 29589323
Mol Metab. 2016 Jun 30;5(8):626-634
pubmed: 27656400
Front Physiol. 2019 Jan 31;10:39
pubmed: 30766490
Physiol Rep. 2019 Mar;7(6):e14031
pubmed: 30873754
Nat Immunol. 2017 May;18(5):519-529
pubmed: 28346409
Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5096-E5105
pubmed: 29760084
Adipocyte. 2015 Jan 07;4(2):123-8
pubmed: 26167415
Am J Physiol Regul Integr Comp Physiol. 2006 Dec;291(6):R1630-7
pubmed: 16887921
Mol Metab. 2018 Oct;16:116-125
pubmed: 30005879
J Biol Chem. 2016 Nov 4;291(45):23390-23402
pubmed: 27621315
Cell Metab. 2018 Jan 9;27(1):226-236.e3
pubmed: 29320703
Obesity (Silver Spring). 2012 Jul;20(7):1355-64
pubmed: 22513494
Cell Metab. 2015 Aug 4;22(2):279-90
pubmed: 26166748
J Endocrinol. 2019 May 10;241(3):R97-R109
pubmed: 31144796
Cell Metab. 2017 Oct 3;26(4):686-692.e3
pubmed: 28918935
Nat Med. 2018 Jun;24(6):814-822
pubmed: 29785025
Clin Sci (Lond). 2020 Mar 13;134(5):473-512
pubmed: 32149342
Elife. 2019 Oct 23;8:
pubmed: 31644425
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):446-51
pubmed: 26712027
Int J Obes (Lond). 2010 Oct;34 Suppl 1:S36-42
pubmed: 20935665
Diabetes. 2018 Feb;67(2):235-247
pubmed: 29133512
J Mol Endocrinol. 2016 Aug;57(2):R93-R108
pubmed: 27194812
AAPS J. 2013 Oct;15(4):1001-11
pubmed: 23821353
Mol Cell. 2011 Dec 23;44(6):851-63
pubmed: 22195961
Mol Metab. 2020 Apr;34:27-42
pubmed: 32180558
Nat Med. 2017 Nov;23(11):1309-1318
pubmed: 29035364
Science. 2019 Apr 26;364(6438):
pubmed: 31023895
Nat Commun. 2018 Nov 26;9(1):4974
pubmed: 30478315
Am J Physiol Regul Integr Comp Physiol. 2005 Apr;288(4):R1028-37
pubmed: 15550613
Cell Metab. 2018 Aug 7;28(2):300-309.e4
pubmed: 29937373
Immunometabolism. 2019;1:
pubmed: 31396408
Biology (Basel). 2019 Feb 12;8(1):
pubmed: 30759876
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Cell. 2014 Jun 5;157(6):1292-1308
pubmed: 24906148
Nature. 2011 Nov 20;480(7375):104-8
pubmed: 22101429
Endocr Rev. 2020 Jan 1;41(1):
pubmed: 31638161
J Exp Biol. 2018 Mar 7;221(Pt Suppl 1):
pubmed: 29514884
Nat Rev Endocrinol. 2019 Apr;15(4):207-225
pubmed: 30733616
Cell Metab. 2016 Sep 13;24(3):434-446
pubmed: 27568549
N Engl J Med. 2009 Apr 9;360(15):1500-8
pubmed: 19357405
Sci Rep. 2019 Feb 4;9(1):1236
pubmed: 30718686
Nature. 2017 Oct 5;550(7674):119-123
pubmed: 28953873
Cell Metab. 2018 May 01;27(5):954-961
pubmed: 29719233
PLoS One. 2011;6(9):e24358
pubmed: 21931688
Nat Metab. 2019 Feb;1(2):189-200
pubmed: 31903450
Methods Mol Biol. 2010;605:189-203
pubmed: 20072882
Cell Metab. 2018 Nov 6;28(5):750-763.e6
pubmed: 30122557
Handb Exp Pharmacol. 2019;251:161-182
pubmed: 29633180
J Immunol Methods. 1994 Sep 14;174(1-2):83-93
pubmed: 8083541
Endocr Regul. 2016 Jul;50(3):137-44
pubmed: 27560796
Nature. 2006 Dec 14;444(7121):847-53
pubmed: 17167472
Mol Endocrinol. 2008 May;22(5):1057-64
pubmed: 18238829
Cell Metab. 2015 Jan 6;21(1):13-4
pubmed: 25565202
Nat Med. 2017 May;23(5):623-630
pubmed: 28414329
Biochem J. 2020 Feb 14;477(3):583-600
pubmed: 32026949
Cell. 2019 Jul 25;178(3):686-698.e14
pubmed: 31257031
Physiol Behav. 2018 Jun 1;190:3-10
pubmed: 28694155
Cell Metab. 2012 Aug 8;16(2):189-201
pubmed: 22863804
Br J Cancer. 2006 Aug 7;95(3):272-81
pubmed: 16832418
Methods Enzymol. 2014;537:199-225
pubmed: 24480348
Nat Rev Endocrinol. 2017 Jan;13(1):26-35
pubmed: 27616452
Nat Med. 2014 Dec;20(12):1436-1443
pubmed: 25401691
Cell Metab. 2017 Oct 3;26(4):672-685.e4
pubmed: 28918936
JCI Insight. 2019 Jan 24;4(2):
pubmed: 30674713
Cell Rep. 2015 Nov 24;13(8):1538-44
pubmed: 26586436
J Clin Invest. 2016 May 2;126(5):1704-16
pubmed: 27018708
J Endocrinol. 2019 Nov;243(2):R19-R27
pubmed: 31419785
Am J Physiol Regul Integr Comp Physiol. 2016 Jul 1;311(1):R79-88
pubmed: 27097660

Auteurs

Felipe Henriques (F)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Alexander H Bedard (AH)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Adilson Guilherme (A)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Mark Kelly (M)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Jingyi Chi (J)

Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY, USA.

Peng Zhang (P)

Life Sciences Institute, University of Michigan Medical Center, Ann Arbor, MI, USA; Department of Cell and Developmental Biology, University of Michigan Medical Center, Ann Arbor, MI, USA.

Lawrence M Lifshitz (LM)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Karl Bellvé (K)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Leslie A Rowland (LA)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Batuhan Yenilmez (B)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Shreya Kumar (S)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Yetao Wang (Y)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Jeremy Luban (J)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Lee S Weinstein (LS)

Metabolic Diseases Branch, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.

Jiandie D Lin (JD)

Life Sciences Institute, University of Michigan Medical Center, Ann Arbor, MI, USA; Department of Cell and Developmental Biology, University of Michigan Medical Center, Ann Arbor, MI, USA.

Paul Cohen (P)

Laboratory of Molecular Metabolism, The Rockefeller University, New York, NY, USA.

Michael P Czech (MP)

Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: michael.czech@umassmed.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH